Home » News » Anti-Diabetic Drug ‘Ayush-82’ to be commercialised

Anti-Diabetic Drug ‘Ayush-82’ to be commercialised

The National Research Development Corporation(NRDC) of the Department of Scientific & Industrial Research, Ministry of Science & Technology signed a License Agreement with Kudos Laboratories India for commercialization of Ayush-82, an ayurvedic formulation for prevention and management of  Diabetes.Ayush-82

It has been developed by Central Council for Research in Ayurvedic Sciences (CCRAS), New Delhi, an apex organization for research in Ayurveda under the Ministry of AYUSH (Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homeopathy).

Chairman & Managing Director NRDC, Dr. H. Purushotham, Prof. Vd. K.S. Dhiman, Director General of CCRAS and Senior Executives/Scientists of NRDC and CCRAS were also present during the event. Prof. Dhiman highlighted about the formulation and its benefits. Dr. H. Purushotham said that patients are preferring Ayurvedic drugs as it can be seen that in the recent past NRDC licensed 12 Ayurvedic drugs developed by CCRAS to 32 companies in India.

Now Kudos Laboratories India could commercialize this product under their trade name with due acknowledgement to CCRAS, Ministry of AYUSH, Government of India.

Don't be shellfish...Share on FacebookShare on Google+Share on LinkedInShare on StumbleUponPin on PinterestTweet about this on Twitter

Share and Enjoy

  • Facebook
  • Twitter
  • Delicious
  • LinkedIn
  • StumbleUpon
  • Add to favorites
  • Email
  • RSS

Leave a Reply

Your email address will not be published. Required fields are marked *


You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

Free WordPress Themes - Download High-quality Templates